Molecular mechanism of Yi-Qi-Yang-Yin-Ye against obesity in rats using network pharmacology, molecular docking, and molecular dynamics simulations

被引:6
|
作者
Sun, Feifei [1 ,2 ]
Liu, Jinde [1 ]
Xu, Jingfei [1 ]
Tariq, Ali [3 ]
Wu, Yongning [2 ]
Li, Lin [1 ]
机构
[1] Anhui Agr Univ, Coll Anim Sci & Technol, Anim Derived Food Safety Innovat Team, Hefei 230036, Peoples R China
[2] Chinese Acad Med Sci, NHC Key Lab Food Safety Risk Assessment, China Natl Ctr Food Safety Risk Assessment, Res Unit 2019RU014, Beijing, Peoples R China
[3] Univ Agr, Coll Vet Sci, Peshawar, Pakistan
基金
中国国家自然科学基金;
关键词
Natural products; Yi-Qi-Yang-Yin-Ye; Obesity; Network pharmacology; Molecular docking; Molecular dynamics simulations; INSULIN-RESISTANCE; ADIPOSE-TISSUE; KINASE; INFLAMMATION; QUERCETIN; PATHWAYS; PROFILE;
D O I
10.1016/j.arabjc.2023.105390
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The increasing prevalence of obesity globally, which as well as affecting people's daily lives and increasing the risk of obesity complications, also threatens the health of animal organisms simultaneously. It's been reported that Yi-Qi-Yang-Yin-Ye had remarkable efficacy in the treatment of obesity. The specific underlying mechanism of action of Yi-Qi-Yang-Yin-Ye in treating obesity, however, remains ambiguous. Therefore, the innovative approach, which is network pharmacology combined with molecular docking and molecular dynamics simulations, was employed in the current research to explore the potential mechanism and promote further development in the treatment of obesity. The active ingredients and related targets of Yi-Qi-Yang-Yin-Ye and related targets of obesity were summarized from extensive public databases. Furthermore, network topology analysis and pathway enrichment analysis were performed to explore the complicated interactions between drug and targets. Finally, accurate validation methods composed of molecular docking and molecular dynamics simulations were conducted to elucidate the binding affinity of Yi-Qi-Yang-Yin-Ye with obesity-related targets. As a result, 13 main active ingredients and 5 core targets of Yi-Qi-Yang-Yin-Ye against obesity in rats were acquired through primary screening of network topology analysis. Pathway enrichment analysis demonstrated that intersectional targets were involved in multiple signaling pathways, where PI3K-Akt signaling pathway, MAPK signaling pathway, and Insulin resistance were the main pathways of Yi-Qi-Yang-Yin-Ye in treating obesity in rats. Finally, molecular docking indicated that the seven critical active ingredients displayed great binding affinity to the hub targets. Furthermore, molecular dynamics simulations further screened and obtained that five critical active ingredients acting on the Mapk1 target for Yi-Qi-Yang-Yin-Ye against obesity in rats. The innovative approach and the results achieved have further contributed to and revealed the molecular mechanisms for treating obesity, providing an alternative for treating obesity in animals and humans.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Integration of molecular docking, molecular dynamics and network pharmacology to explore the multi-target pharmacology of fenugreek against diabetes
    Luo, Wenfeng
    Deng, Jie
    He, Jiecheng
    Yin, Liang
    You, Rong
    Zhang, Lingkun
    Shen, Jian
    Han, Zeping
    Xie, Fangmei
    He, Jinhua
    Guan, Yanqing
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2023, 27 (14) : 1959 - 1974
  • [22] Combining network pharmacology, molecular docking, molecular dynamics simulation, and experimental verification to examine the efficacy and immunoregulation mechanism of FHB granules on vitiligo
    Li, Xiaolong
    Miao, Fengze
    Xin, Rujuan
    Tai, Zongguang
    Pan, Huijun
    Huang, Hao
    Yu, Junxia
    Chen, Zhongjian
    Zhu, Quangang
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [23] Elucidation of the Molecular Mechanism of Compound Danshen Dripping Pills Against Angina Pectoris based on Network Pharmacology and Molecular Docking
    Tian, Xiaocui
    Yin, Shiqi
    Liu, Zhiguang
    Cao, Jinglin
    Liu, Xinyu
    Qiu, Qi
    CURRENT PHARMACEUTICAL DESIGN, 2024, 30 (16) : 1247 - 1264
  • [24] Mechanism of American Ginseng Against Type 2 Diabetes Mellitus Based on Network Pharmacology & Molecular Docking
    Li, Jiaxin
    Chen, Siqi
    Wang, Bo
    Xie, Jiaming
    Wu, Xinyu
    Hu, Xinying
    Liu, Jing
    Zhang, Yi
    Wang, Junzhi
    Ge, Pengling
    LETTERS IN DRUG DESIGN & DISCOVERY, 2024, 21 (11) : 2046 - 2062
  • [25] Network pharmacology integrated with molecular docking and molecular dynamics simulations to explore the mechanism of Tongxie Yaofang in the treatment of ulcerative colitis
    Tang, Lili
    Liu, Yuedong
    Tao, Hongwu
    Feng, Wenzhe
    Ren, Cong
    MEDICINE, 2024, 103 (36)
  • [26] Exploring the active ingredients and mechanisms of Liujunzi decoction in treating hepatitis B: a study based on network pharmacology, molecular docking, and molecular dynamics simulations
    Ma, Qing
    Li, Wenjun
    Wu, Wenying
    Sun, Mei
    COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING, 2024,
  • [27] Network Pharmacology, Molecular Docking, Molecular Dynamics to Explore the Mechanism of Danggui Shaoyao Powder for Hepatic Encephalopathy
    Zhang, Miao
    Liu, Rongxin
    Zhao, Yusen
    Chen, Zixin
    Zhai, Honglin
    Si, Hongzong
    CURRENT PHARMACEUTICAL DESIGN, 2025,
  • [28] Study on the Mechanism of Paeoniflorin Against Atherosclerosis Through Network Pharmacology and Molecular Docking
    Zhao, Chengguo
    Ling, Wenpei
    Luo, Chunyu
    Yin, Meifang
    Qin, Shuzhi
    JOURNAL OF BIOBASED MATERIALS AND BIOENERGY, 2020, 14 (04) : 467 - 475
  • [29] Exploring the Mechanism of Gyejibokryeong-hwan against Atherosclerosis Using Network Pharmacology and Molecular Docking
    Lee, A. Yeong
    Lee, Joo-Youn
    Chun, Jin Mi
    PLANTS-BASEL, 2020, 9 (12): : 1 - 21
  • [30] Network pharmacology and molecular docking reveal the mechanism of Angelica dahurica against Osteosarcoma
    Zhang, Yafang
    Li, Zhehong
    Wei, Junqiang
    Kong, Lingwei
    Song, Mingze
    Zhang, Yange
    Xiao, Xiangyu
    Cao, Haiying
    Jin, Yu
    MEDICINE, 2022, 101 (44) : E31055